Add-on doxofylline for stable COPD
Part of Lungs & breathing clinical trials.
This trial tests whether adding a medicine called doxofylline to your usual COPD inhalers can improve your lung function. It is for people with stable COPD who are already taking two types of long-acting inhalers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had COPD for at least 6 months.
- Your lung function (FEV1) is 80% or less of what is expected for your age and height.
- You are a current or former smoker with a history of 10 pack-years or more (e.g., 1 pack a day for 10 years).
- You are already taking a long-acting muscarinic antagonist (LAMA) and a long-acting beta-2 agonist (LABA) inhaler, with or without an inhaled corticosteroid (ICS).
- Your COPD has been stable for the last 6 months (no sudden flare-ups).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether breathing in nitric oxide gas can improve how well your lungs exchange oxygen and carbon dioxide. It may help people with mild or moderate COPD, and also includes healthy volunteers for comparison.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
This Phase 3 trial tests whether adding doxycycline to standard TB medicine can improve lung function and reduce lung tissue damage. It aims to see if patients recover better by targeting the lung response to TB.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This trial tests a once-daily inhaler that combines a long-acting bronchodilator with a corticosteroid to see if it improves breathing, lung function, and quality of life in people with moderate-to-severe COPD who have significant shortness of breath.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.